Mark Lackner
Senior Vice President, Head of Biology and Translational Sciences
Other
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former Chief Scientific Officer | $153,553 | $1,229,349 |
| 2024 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former Chief Scientific Officer | $484,397 | $4,788,822 |
Earnings-call appearances
No earnings-call appearances recorded yet.